- Home
- » Tags
- » Mode of action
Top View
- Extracellular Vesicles As a Next-Generation Drug Delivery Platform
- Metaphors in Nanomedicine: the Case of Targeted Drug Delivery Bernadette Bensaude Vincent, Sacha Loeve
- Chapter 3: Mechanisms and Mode of Dioxin Action
- In Silico Identification of Novel Chemical Compounds with Anti-TB Potential for the Inhibition
- Nutrients and Phytochemicals: from Bioavailability to Bioefficacy Beyond
- The Screening Compound Collection: a Key Asset for Drug Discovery
- NAFTA Technical Working Group on Pesticides Quantitative Structure Activity Relationship Guidance Document
- The Hitchhiker's Guide to Clinical Pharmacology
- Presentation Are My Own, and May Not Necessarily Be Shared by Other Assessors at the Mhra Or Swp
- Formulation-Dependent Toxicokinetics Explains Differences in the GI
- Principles of Medicinal Chemistry
- Enzyme Inhibitors and Activators Enzyme Inhibitors and Activators
- Medicinal Chemistry - Fulvio Gualtieri
- 2019 Antibacterial Agents in Clinical Development
- Irac Mode of Action Classification Scheme
- Xanthones, a Promising Anti-Inflammatory Scaffold: Structure, Activity, and Drug Likeness Analysis
- Prioritization of Anti-Malarial Hits from Nature: Chemo-Informatic Profiling Of
- CHAPTER 18 MEDICINAL CHEMISTRY 18.1 Introduction
- Proper Knowledge on Toxicokinetics Improves Human Hazard Testing and Subsequent Health Risk Characterisation. a Case Study Approach ⇑ Jos G.M
- Enzyme Inhibition
- Summary of Herbicide Mechanism of Action According to the Weed Science Society of America (WSSA)
- Antibiotics in the Clinical Pipeline in October 2019
- Drug Repositioning and Indication Discovery Using Description Logics
- Anti-Staphylococcal Activity and Mode of Action of Thioridazine Photoproducts
- Investigation of the Mechanism of Action for Mithramycin and the Biosynthesis of L-Rednose in Saquayamycins
- An FDA/CDER Perspective on Nonclinical Testing Strategies
- Precision Medicine and Site-Specific Drug Delivery
- Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects
- Palleros – Medicinal Chemistry I
- Applied Sciences
- Physico-Chemical Characteristics and Quantitative Structure-Activity Relationships of Pcbs
- Quantitative Structure Activity Relationship (QSAR) Studies on Nitazoxanide-Based Analogues Against Clostridium Difficile in Vitro
- (+)-Meptazinol: an Opioid with Mixed Anal- Gesic Pharmacophores1
- Studies of the Pharmacodynamics and Modes of Action of Anthelmintic Drugs
- The Bioactive Potential of Functional Products and Bioavailability of Phenolic Compounds
- Mode of Action Approach for Specifically Acting Chemicals
- 3D Pharmacophores As Tools for Activity Profiling
- Tier- Wise Collection of PK Data That Would Better Define Dose Across… – Species – Life Stages – Route – Frequency and Duration of Exposure Objectives (Continued)
- Bioavailability and Corneal Anti-Inflammatory Effect of Topical Suprofen
- 4 Chemogenomics
- Analysis of Different Innovative Formulations of Curcumin for Improved Relative Oral Bioavailability in Human Subjects
- Presentation: from Mode of Action to Adverse Outcome Pathways
- Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
- Mechanistic Enzymology in Drug Discovery: a Fresh Perspective
- Principles of Organic Medicinal Chemistry Is Concerned with Chemistry, Synthesis, Struc- Ture Activity Relationships, Properties and Uses of Drugs of Carbon Compounds
- Discovery of Drug Mode of Action and Drug Repositioning from Transcriptional Responses
- Mechanistic Insights on the Mode of Action of an Antiproliferative
- (QSAR) Studies on the Toxic Effects of Nitroaromatic Compounds (Nacs): a Systematic Review
- S7A Safety Pharmacology Studies for Human Pharmaceuticals
- Drug Discovery Glossary Copyright 2015
- Pharmacodynamics of Drugs in Relation to Human Body
- Oecd Guideline for the Testing of Chemicals
- Pharmaceutical (Medicinal) Chemistry Introduction